ZS Pharma Offers Top-Line Results from HARMONIZE (ZS004) Phase 3 Trial of ZS-9
September 23, 2014 at 16:01 PM EDT
ZS Pharma (Nasdaq: ZSPH), a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic ...